Icecure Medical is trading at $1.17, up +6.36% in pre-market, with no clear catalyst identified.
- No new company announcement dated October 12 was found; the latest listed release, dated October 6, concerns an added clinical site for its ChoICE study.
- Healthcare is up 1.58% pre-market, offering a possible sector tailwind, while broad indices are mixed.
- Shares also rose after hours on October 9 without a clear catalyst.